Early experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trial

Vista senzilla d'ítem
dc.contributor.authorFerrer, Ferran
dc.contributor.authorPont, Àngels
dc.contributor.authorBlas, Rodolfo de
dc.contributor.authorBoladeras, Anna
dc.contributor.authorGarin, O.
dc.contributor.authorVentura, Montse
dc.contributor.authorZardoya, Eva
dc.contributor.authorDelgado, J.
dc.contributor.authorCondom, E.
dc.contributor.authorMerino Cabrera, Esperanza
dc.contributor.authorMases, Joel
dc.contributor.authorCastells-Esteve, Manel
dc.contributor.authorGuix, Inés
dc.contributor.authorSuárez-Novo, José Francisco
dc.contributor.authorGonzalez, Javier
dc.contributor.authorAlmendros, Sonia
dc.contributor.authorGarcia, M.
dc.contributor.authorBerenguer, Miguel Ángel
dc.contributor.authorGarcia, N.
dc.contributor.authorStefanovic, M.
dc.contributor.authorGutierrez, Cristina
dc.contributor.authorPicon, Cristina
dc.contributor.authorFerrer, Montserrat
dc.contributor.authorGuedea Edo, Ferran
dc.date.accessioned2021-05-25T07:25:16Z
dc.date.available2021-05-25T07:25:16Z
dc.date.issued2019-04-01
dc.date.updated2021-03-10T14:05:31Z
dc.description.abstractPurpose or ObjectiveExtracranial stereotactic body radiation therapy (SBRT) allows delivering high doses per fraction with high accuracy to the prostatic gland in a low number of fractions.Dose escalation in normofractionaded radiation prostate cancer trials showed an increased toxicity.In order to evaluate the feasibility and toxicity of a regimen of a single dose hypofractionated prostate stereotactic boost a phase II study was undertaken. Self-reported quality of life (QOL) measures were also obtained in order to better define the possible deleterious effect of treatment.ca
dc.format.mimetypeapplication/pdf
dc.identifier.issn0167-8140
dc.identifier.urihttps://hdl.handle.net/2445/177558
dc.language.isoengca
dc.publisherElsevier BVca
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/S0167-8140(19)31959-0
dc.relation.ispartofRadiotherapy and Oncology, 2019, vol. 133, p. S830-S831
dc.relation.urihttps://doi.org/10.1016/S0167-8140(19)31959-0
dc.rightscc by-nc-nd (c) Elsevier Ireland Ltd, 2019
dc.rights.accessRightsinfo:eu-repo/semantics/openAccessca
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationRadioteràpia
dc.subject.classificationCàncer de pròstata
dc.subject.otherRadiotherapy
dc.subject.otherProstate cancer
dc.titleEarly experience and quality of life in SBRT prostate cancer boost of 9 Gy in a phase II trialca
dc.typeinfo:eu-repo/semantics/conferenceObjectca
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
PIIS0167814019319590.pdf
Mida:
2.23 MB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))